Archived research. The play portfolio is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
DCH
Dauch Corporation
2.4%
+5.3%
$5.61
$5.91
Why This Position Exists
Dauch Corporation is classified as price-below-value with MEDIUM confidence following a transformational acquisition of Dowlais (GKN). The prediction ensemble shows the most severe downside scenarios are low-probability: Q1 EBITDA miss below $300M at 32%, NA auto production collapse at 22%, and GAAP profitability in 2026 at 12% (an accounting inevitability, not operational failure). Meanwhile, synergy achievement registers at 60% favorable, and the 72% probability of leverage staying above 3.0x is mechanically expected and already embedded in the $5.61 price. At ~5x guided EBITDA ($1,350M midpoint) and an enterprise value of ~$9.1B, the stock appears to price in significant integration failure that the ensemble does not support.
Trigger: Initial thesis assessment for DCH generated 2026-03-27 from analysis run DCH-2026-03-27. Five-lens analysis converged on HIGHER_SCRUTINY posture with concerns about leverage, synergy execution, GM T1XX concentration, and GAAP/adjusted divergence. However, insider alignment (director purchases at $5.20) and powertrain-agnostic positioning provide meaningful counterweights.
Key Market Signals
Committee Verdict
The Portfolio Analyst correctly identified DCH as price-below-value at MEDIUM confidence, with a compelling valuation case: ~5x guided EBITDA for the world's largest independent driveline supplier, with insider purchases at $5.20 reinforcing conviction. The Risk Manager's quarter-Kelly sizing at 2.4% already incorporates the highest tail risk discount (-0.30) of any recent evaluation, reflecting the three escalating markets (leverage, production, metal forming) -- this mechanical conservatism addresses the Devil's Advocate's legitimate concern about leverage fragility. The DA's strongest challenge -- zero combined operating history making every probability estimate extrapolated -- is valid but does not change the decision because (1) Q1 earnings in August will resolve this uncertainty within months, (2) the standalone EBITDA floor ($186M AAM + $120M Dowlais) provides mathematical evidence the $300M quarterly threshold is achievable, and (3) the position size is small enough to absorb a 30%+ drawdown during the information vacuum. The tariff risk and governance opacity concerns are acknowledged as genuine monitoring triggers but do not rise to thesis-invalidating level at current position sizing.
Devil's Advocate
mixedThe thesis has legitimate analytical support: the ensemble identifies low probability of severe downside scenarios, insider alignment is genuine, and the 5x EBITDA valuation is objectively low for a global #1 driveline supplier. However, the zero combined operating history creates a fundamental uncertainty that the ensemble may underweight -- every probability is extrapolated from standalone data. The leverage burden is real, the synergy thesis is untested in practice, and the tariff/macro risks introduce genuine unknowable variables. The quarter-Kelly sizing (2.4%) appropriately sizes the position for this uncertainty profile, but the three high-severity tail risk discounts already embedded in the Kelly formula suggest the formula itself is signaling elevated risk. The position is defensible at this size but should be considered high-monitoring-burden relative to its small weight.
Notable Dissent
Devil's Advocate raised a valid structural concern: the zero combined operating history means every ensemble probability is extrapolated from standalone data, and the 60% synergy achievement probability may overweight a static pre-close audit. Additionally, the leverage burden ($4.2B net debt, ~$50M annual free cash for paydown) provides minimal margin for error. These concerns are acknowledged but overridden because (1) the standalone EBITDA floor provides mathematical underpinning for near-term estimates, (2) the Kelly formula's -0.30 tail risk discount already embeds elevated risk into the sizing, and (3) Q1 results will resolve the information vacuum within months. The position is approved at 2.4% with high monitoring burden.
Monitoring Triggers
• Re-evaluate on Q1 2026 pro forma results (expected August 2026) -- the first combined quarterly report is thesis-defining
• Re-evaluate if any indication synergy run-rate is tracking below $75M annualized by H2 2026
• Re-evaluate if NA auto production forecast drops below 14.5M for any quarter
• Re-evaluate if tariff policy changes materially affect auto supply chain economics
• Mandatory review if position return drops below -25%
• Re-evaluate if stock price exceeds $7.50 (34% upside from entry) -- assess whether valuation gap has narrowed
Position Details
Mar 27, 2026
427
price-below-value
MEDIUM
Auto Components
1
Kelly Sizing Breakdown
EDGE
ODDS
KELLY
Trade History
| Date | Action | Shares | Price | Weight | Rationale |
|---|---|---|---|---|---|
| Mar 27, 2026 | OPEN | 427 | $5.61 | 0.0% → 2.4% | Compelling valuation at ~5x guided EBITDA for world's largest independent driveline supplier. Insider purchases at $5.20 reinforce conviction. Highest tail risk discount (-0.30) reflects leverage and integration risk, sized conservatively at 2.4%. |
Full Committee Transcripts (1)
Complete 4-step discourse records — expand each step to see the full reasoning from analyst, risk manager, devil's advocate, and committee chair.